References & Evidence Policy

How we rank sources

1. Current product label for serving size, ingredient names, label directions and cautions.
2. Current seller/checkout information for price, package and offer terms.
3. Seller support policies for shipping and refund procedures.
4. FDA and other authoritative bodies for regulatory context.
5. PubMed/Cochrane/peer-reviewed research for ingredient and microbiome science.

Product and seller sources

• Supplied FemiCore Supplement Facts label
• Seller refund policy
• Seller shipping policy
• Seller scientific-reference list

Independent regulatory and scientific sources

• FDA: Questions and Answers on Dietary Supplements
• FDA: Structure/Function Claims
• Cochrane: Cranberries for preventing urinary tract infections (2023)
• Interconnected microbiomes—female urogenital health review
• Mimosa pudica review
• Uva-ursi/bearberry safety review
• Berberine-drug interactions review (2026)
• Lactobacillus acidophilus review
• Lactobacillus plantarum review
• Lactobacillus gasseri/crispatus colonization study
• Lactobacillus casei group review
• Review of Lactobacillus probiotic strains

Evidence limits

Research on cranberry, berberine, bearberry, Mimosa pudica or a Lactobacillus species does not automatically prove the effectiveness of the finished FemiCore supplement. Strain, dose, formulation, viability, population and study design all affect relevance. We have not identified a published clinical trial of the finished FemiCore product.